iX Biopharma Ltd. (Catalist: 42C)
Health Care · Pharmaceuticals · SG
S$0.53
-5.36% today · +476.1% 1Y
iX Biopharma Ltd. (Catalist: 42C) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $452.33M.
Over the last twelve months the share price has gained 476.1%, trading between 0.08 and 0.63.
Tweenvest scores iX Biopharma Ltd. across four factors: quality 36/100, value 62/100, growth 20/100. Its strongest factor is value.
42C price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $452.33M
- Revenue (TTM)
- $5.30M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.01
- 52-week high
- S$0.63
- 52-week low
- S$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 1.09B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tuoxin Pharmaceutical Group Co.,Ltd.SZSE: 301089 | $464.38M | CN¥24.58 | +0.33% |
| Myung In Pharmaceutical LTD.KOSE: A317450 | $462.09M | ₩42,550.00 | -2.52% |
| Shanghai Kai Kai Industry Company LimitedSHSE: 600272 | $461.00M | CN¥15.65 | +4.26% |
| Vireo Growth Inc.CNSX: VREO | $457.48M | CA$13.37 | -2.41% |
| DHG Pharmaceutical Joint Stock CompanyHOSE: DHG | $450.55M | ₫89,200.00 | -0.22% |
| Jiangxi Synergy Pharmaceutical Co., Ltd.SZSE: 300636 | $448.91M | CN¥7.16 | +0.99% |
| JW Pharmaceutical CorporationKOSE: A001060 | $447.47M | ₩26,350.00 | -1.50% |
| AgomAb Therapeutics NVNasdaqGS: AGMB | $447.17M | $9.24 | +1.71% |
Figures last refreshed Oct 11, 2026.